Quantcast

Latest Oncogenes Stories

2014-12-16 08:31:43

-- Novel irreversible pan-erbB inhibitor is active against patient-derived GBM xenografts overexpressing EGFR, including the disease-driving EGFRvIII mutation MENLO PARK, Calif., Dec.

2014-12-11 08:28:27

Studies Using Caris Molecular Intelligence(TM) Identify Standard as well as Novel Therapeutic Options Based on Molecular Characterization of Individual Patients' Tumors IRVING, Texas,

2014-11-20 12:32:20

Study May Lead to More Targeted Treatments for Cancers and "Rasopathies" CINCINNATI, Nov.

2014-11-06 16:35:38

SAN DIEGO, Nov. 6, 2014 /PRNewswire/ -- Trovagene, Inc.

2014-10-27 08:26:15

Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO, Oct.

2014-10-01 08:31:58

BRAF V600E assay improves determination of mutational status and allows monitoring of treatment response SAN DIEGO, Oct.

2014-09-29 08:30:43

- Median overall survival is encouraging for this patient population - BOULDER, Colo., Sept.

2014-08-18 08:28:34

Proceedings of the National Academy of Sciences Study Shows Ability to Create Therapeutics Targeting Critical MYC Regulator for Potential Treatment of Cancer SAN DIEGO, Aug.

2014-06-25 11:27:24

A key cancer-causing gene, responsible for up to 20 percent of cancers, may have a weak spot in its armor.

2014-06-10 12:30:10

MADISON, N.J., June 10, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new cancer test service based


Word of the Day
plim
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.
Related